Target intelligence / Profile preview

CFAP100 divergent transcript (CFAP100-DT)

Target
CFAP100-DT
Molecular classification
Long non-coding RNA, Divergent transcript, Other
01

Overview

CFAP100 divergent transcript (CFAP100-DT) is a long non-coding RNA gene, categorized as a *divergent transcript* due to its orientation and proximity relative to neighboring coding genes such as CCDC37[3][5]. Divergent lncRNAs are typically transcribed from promoters shared with an adjacent protein-coding gene but in the opposite (head-to-head) direction. These lncRNAs contribute to local chromatin remodeling and transcriptional regulation of themselves and neighboring genes, though the precise function of CFAP100-DT remains undetermined[3][5]. Currently, CFAP100-DT is not considered a therapeutic target nor is it associated with drug interactions, disease roles, or biomarkers for therapy selection.

Other names
CCDC37-AS1CCDC37-DTCCDC37 antisense RNA 1 (head to head)CCDC37 divergent transcriptCFAP100-DT
02

Biological functions

Chromatin regulationTranscriptional regulationEpigenetic regulationOther
03

Disease associations

Other

Beyond the preview

Go deeper on CFAP100 divergent transcript (CFAP100-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CFAP100 divergent transcript (CFAP100-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call